10.1039/P19890001177
The research aims to synthesize and evaluate a series of novel cis- and trans-3-(octahydro-1H-pyrano[4,3-c]pyridin-8a-yl)phenols and related thiopyrano systems for their antinociceptive activity and opioid receptor profiles. The study employs alkylation and hydrogenation techniques to generate these compounds. 1-methyl-4-(3-methoxyphenyl)-1,2,3,6-tetrahydropyridine (7) serves as the foundational starting material, while 2-chloro-1-(chloromethoxy)ethane acts as a key alkylating agent. Together, they enable the synthesis of the intermediate enamine (8a) and the subsequent formation of the bicyclic enamine (9a), which are essential steps in the construction of the target compounds. The synthesized compounds are then tested in vivo using the mouse acetylcholine-induced abdominal constriction test and the rat urine output model, and in vitro using the guinea-pig ileum and rabbit vas deferens preparations. The results show that certain derivatives, like (13l) and (21c), exhibit high potency and selective K-agonist profiles, indicating their potential as safer analgesics compared to traditional morphine-like drugs. The study concludes that the combination of new in vivo and in vitro test systems effectively distinguishes between μ- and K-agonists, providing valuable insights into the structure-activity relationships of these novel compounds.